Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|FT671||FT671 is a small molecule inhibitor of USP7, which leads to increased levels of Tp53, thereby inducing Tp53 substrates and potentially resulting in cell growth arrest and apoptosis (PMID: 29045389).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||multiple myeloma||not applicable||FT671||Preclinical - Cell line xenograft||Actionable||In a preclinical study, FT671 treatment blocked proliferation of multiple myeloma cells in culture and inhibited tumor growth in multiple myeloma cell line xenograft models (PMID: 29045389).||29045389|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|